JMS have previously indicated the payout % ( as dividends) from profits in future will be circa 70%. The balance of 30% can be used to grow the company I guess with value accretive options as they say. Based on my calcs, in broad terms, assuming 70% payouts and a return to historical Mn prices and AUD/USD 75c, and output around the current 3.3 mill tonnes, its still gives a divvy of about 4c per share annualized. That's 10-11% divvy yield, unfranked. If the Mn prices stay where they are now, and the AUD remains in low 70's cents range, 5.5 - 6 cents divvy per share annualized is achieved, again after allowing for a 70% payout from earnings. That's a very very good yield at current share price sub 40c. If the share price falls back ex divvy date, it represents a further excellent buying opportunity (top-ups) either way. I am fully loaded, but if there is a pull-back I will wade in for more. Being unfranked divvies, also don't also have to worry about looney Labor stealing franking credits from SMSF's ( which includes me)
- Forums
- ASX - By Stock
- JMS
- Ann: Jupiter Declares 14.5% Yielding H1 2019 Dividend
Ann: Jupiter Declares 14.5% Yielding H1 2019 Dividend, page-27
-
- There are more pages in this discussion • 207 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JMS (ASX) to my watchlist
|
|||||
Last
26.5¢ |
Change
-0.005(1.85%) |
Mkt cap ! $519.4M |
Open | High | Low | Value | Volume |
27.0¢ | 27.0¢ | 26.0¢ | $1.020M | 3.838M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 238721 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.0¢ | 58916 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 223721 | 0.260 |
7 | 713812 | 0.255 |
12 | 1073901 | 0.250 |
6 | 302000 | 0.245 |
6 | 288336 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.270 | 58916 | 1 |
0.275 | 1428054 | 8 |
0.280 | 329046 | 5 |
0.285 | 322587 | 4 |
0.290 | 410975 | 5 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
JMS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online